Home > About the AACR > Newsroom >
PHILADELPHIA – A HER2-targeted antibody-drug conjugate, fam-trastuzumab deruxtecan-nxki (Enhertu), showed signs of clinical activity in multiple non-breast/non-gastric cancer types,...
PHILADELPHIA – Using standard-of-care computed tomography (CT) scans in patients with advanced non-small cell lung cancer (NSCLC), researchers utilized...
PHILADELPHIA – The protein peptidyl arginine deiminase 4 (PAD4), which enables some immune cells to trap bacteria, promoted breast...
PHILADELPHIA — The Pancreatic Cancer Collective, the strategic partnership of Lustgarten Foundation and Stand Up To Cancer (SU2C), has...
Cancer experience affects work performance, career decisions, and personal debt PHILADELPHIA – Young women with breast cancer experienced substantial...
Project Renewal will update medical product labeling to allow patients and health care providers to make informed treatment decisions...
PHILADELPHIA – The use of cigarettes with low nicotine content did not result in compensatory smoking, according to results...
PHILADELPHIA – The American Association for Cancer Research (AACR) will receive $2 million from the UBS Oncology Impact Fund...
PHILADELPHIA — The Pezcoller Foundation-AACR International Award for Extraordinary Achievement in Cancer Research will be presented to John E....
PHILADELPHIA – The loss of one copy of the miR15a/miR16-1 gene cluster promoted initiation and progression of multiple myeloma...